American Beacon ARK Transformational Innovation Fund Class C ADNCX

Morningstar Medalist Rating
  • NAV / 1-Day Return $21.00  /  −4.46 %
  • Fund Size $158.6M
  • Adjusted Expense Ratio 2.160%
  • Net Expense Ratio 2.120%
  • Fee Level: Distribution Above Average
  • Share Class Type Level Load
  • Morningstar Category Technology
  • Equity Style Box (Funds) Large Growth
  • Minimum Initial Investment $1,000
  • Investment Status Open
  • TTM Yield 0.00%
  • Turnover Ratio 47%

Morningstar’s Analysis ADNCX

Will ADNCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still fragile, but firmer around the edges.

Principal Robby Greengold

Robby Greengold

Principal

Summary

ARK Innovation’s investment team promises investors a front-row seat to the future, and its broad calls on technologies such as artificial intelligence, biotechnology, and robotics have often been directionally correct. However, it hasn’t shown a strong ability to identify the themes’ biggest winners while prudently managing the portfolio’s extreme risks.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ADNCX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 49.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Tesla Inc

9.12 16M
Consumer Cyclical

Space Exploration Technologies Corp Class A

6.20 11M
Industrials

Tempus AI Inc Class A common stock

5.67 10M
Healthcare

Coinbase Global Inc Ordinary Shares - Class A

4.93 9M
Financial Services

Circle Internet Group Inc Ordinary Shares - Class A

4.76 8M
Financial Services

CRISPR Therapeutics AG

4.38 8M
Healthcare

U.S. Government Money Market S

4.30 8M
Cash and Equivalents

Twist Bioscience Corp

4.18 7M
Healthcare

Robinhood Markets Inc Class A

3.72 7M
Financial Services

10x Genomics Inc Ordinary Shares - Class A

3.13 6M
Healthcare

Sponsor Center